Phylos and People Science Reveal Clinical Study Outcomes Demonstrating the Stimulating Impact of Tetrahydrocannabivarin (THCV) on Energy Levels

Pharmacological News: THCV's Energizing Impact

Overview

  • Company: Phylos
  • Indication: Energizing Effects
  • Drug: Natural Natural THCV
  • Trial Phase: N/A
  • NCT ID: Not applicable

Study Findings

Phylos, a cannabis genetics company, along with People Science, has conducted an IRB-endorsed clinical study on THCV’s energizing effects. The study was placebo-controlled and double-blind and showed that Natural Natural THCV significantly increased energy levels and well-being without the fatigue and increased appetite usually associated with THC.

Product Development

Following the study, Phylos launched the Natural Natural brand, focusing on rare natural cannabinoids. They aim to offer high-quality, scientifically-backed well-being products.

Technology and Innovation

Phylos offers Production-Ready Seed™ to support commercial cultivation. The company leverages pioneering technologies for access to rare cannabinoid genetics. Meanwhile, People Science offers Chloe, a mobile app and data management tool for customizing alternative medical treatments and facilitating clinical research.